Variation in pediatric emergency department care of sickle cell disease and fever

Academic Emergency Medicine

Volumn 22, Issue 4, 2015, Pages 423-430

  Ellison, Angela M ^a   Thurm, Cary ^b   Alessandrini, Evaline ^c   Jain, Shabnam ^d   Cheng, John ^d   Black, Kelly ^e   Schroeder, Lisa ^f   Stone, Kimberly ^g   Alpern, Elizabeth R ^h  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b Children's Health Care Associ   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d EMORY UNIVERSITY   (United States)

^e UNIVERSITY OF SOUTH DAKOTA   (United States)

^f CHILDREN S MERCY HOSPITAL   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ANTIBIOTIC THERAPY; BLOOD CELL COUNT; BLOOD CULTURE; CHILD; CHILDHOOD DISEASE; CLINICAL PRACTICE; COHORT ANALYSIS; CONFERENCE PAPER; CROSS-SECTIONAL STUDY; EMERGENCY CARE; EMERGENCY WARD; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUBLIC HEALTH INSURANCE; RETICULOCYTE COUNT; RETROSPECTIVE STUDY; SICKLE CELL ANEMIA; THORAX RADIOGRAPHY; AGE; ANEMIA, SICKLE CELL; EMERGENCY HEALTH SERVICE; HOSPITAL; ORGANIZATION AND MANAGEMENT; PRESCHOOL CHILD; RADIOGRAPHY; RISK; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADOLESCENT; AGE FACTORS; ANEMIA, SICKLE CELL; ANTI-BACTERIAL AGENTS; BLOOD CELL COUNT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; FEVER; HOSPITALS, PEDIATRIC; HUMANS; INFANT; MALE; ODDS RATIO; PATIENT ADMISSION; RADIOGRAPHY, THORACIC; UNITED STATES;

EID: 84926632276     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/acem.12626     Document Type: Conference Paper

References (21)

1. Zarkowsky HS, Gallagher D, Gill FM, et al. Bacteremia in sickle hemoglobinopathies. J Pediatr 1989; 109: 579-85.
2. Ellison AM, Ota V, McGowan KL, Smith-Whitley K,. Epidemiology of blood stream infections in children with sickle cell disease. Pediatr Infect Dis J 2013; 32: 560-3.
3. Ellison AM, Ota V, McGowan KL, Smith-Whitley K,. Pneumococcal bacteremia in a vaccinated pediatric sickle cell disease population. Pediatr Infect Dis J 2013; 31: 534-6.
4. McCavitt TL, Quinn CT, Techasaensiri C, Rogers ZR,. Increase in invasive Streptococcus pneumoniae infection in child with sickle cell disease since pneumococcal conjugate vaccine license. J Pediatr 2011; 158: 505-7.
5. Adamkiewicz TV, Silk BJ, Howgate J, et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics 2008; 121: 562-9.
6. National Heart, Lung and Blood Institute. The Management of Sickle Cell Disease. 4th ed. Bethesda, MD: National Institutes of Health, 2002. Available at: http://www.nhlbi.nih.gov/files/docs/guidelines/sc-mngt.pdf. Accessed Jan 5, 2015.
7. Section on Hematology/Oncology Committee on Genetics; American Academy of Pediatrics. Health supervision for children with sickle cell disease. Pediatrics 2002; 109: 526-35.
8. Fisher BT, Lindenaue PK, Feudtner C,. In hospital databases. in:, Strom BL, Kimmel SE, Hennessy S, eds. Pharmacoepidemiology, 5th ed. Oxford, UK: Wiley-Blackwell, 2012: 244-58.
9. Baker MD, Bell LM, Avner JR,. Outpatient management without antibiotics of fever selected infants. N Engl J Med 1993; 329: 1437-41.
10. Baskin MN, O'Rourke EJ, Fleisher GR,. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone. J Pediatr 1992; 120: 22-7.
11. Jaskiewicz JA, McCarthy CA, Richardson AC, et al. Febrile infants at low risk for serious bacterial infection-an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. Pediatrics 1994; 94: 390-6.
12. Jain S, Cheng J, Alpern ER, et al. Management of febrile neonates in US pediatric emergency departments. Pediatrics 2014; 133: 187-95.
13. Goyal M, Donoghue A, Schwab S, Hasbrouk N, Khojasten S, Osterhoudt K,. Severe hemolytic crisis after ceftriaxone administration. Pediatr Emerg Care 2011; 27: 322-3.
14. Baskin MN, Goh XL, Heeney M, Harper MB,. Bacteremia risk and outpatient management of febrile episodes in sickle cell disease. Pediatrics 2013; 131: 1035-41.
15. Rogovik AL, Friedman JN, Persuad J, Goldman RD,. Bacterial blood cultures in children with sickle cell disease. Am J Emerg Med 2010; 28: 511-4.
16. Frush K, Ware RE, Kinney TR,. Emergency department visits by children with sickle cell hemoglobinopathies: factors associated with hospital admission. Pediatr Emerg Care 1995; 11: 9-12.
17. Stallworth JR, Jerrell JM, Tripathi A,. Cost effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. Am J Hematol 2010; 85: 795-7.
18. Sobota A, Graham DA, Heeney MM, Neufield EJ,. Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission. Am J Hematol 2010; 85: 24-8.
19. Lanzkron S, Carroll CP, Haywood C Jr,. The burden of emergency department use for sickle cell disease: an analysis of the national emergency department sample database. Am J Hematol 2010; 85: 797-9.
20. Jan S, Slap G, Smith-Whitley K, Dai D, Keren R, Rubin DM,. Association of hospital and provider type on sickle cell disease outcomes. Pediatrics 2013; 152: 854-61.
21. Schwartz LA, Radcliffe J, Barakat LP,. Association of school absenteeism in adolescents with sickle cell disease. Pediatr Blood Cancer 2009; 52: 92-6.